Hello I'm Raiyyan Tahsan
Brand Model and Executive

TC(1373).(09).Gynecology Department Case No (47):-Postprocedural Pelvic Pain and Mild Vaginal Bleeding Following Treatment for Cervical Erosion, with History Suggestive of Subclinical Hypothyroidism (1Prescription+0Report+0Image) 2525

Prescription Attached:-

đŸŠē LIPU MED — COMPLETE CLINICAL PRESCRIPTION REVIEW

āĻŦāĻžāĻ‚āϞāĻž āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧ: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āχāϰ⧋āĻļāύ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āϤāϞāĻĒ⧇āĻŸā§‡ āĻŦā§āϝāĻĨāĻž āĻ“ āĻ…āĻ˛ā§āĻĒ āϝ⧋āύāĻŋāĻĒāĻĨ⧇ āϰāĻ•ā§āϤāĻĒāĻžāϤ; āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŦāĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻšāĻžāχāĻĒā§‹āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄāĻŋāϜāĻŽā§‡āϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻĒā§‚āĻ°ā§āĻŦāχāϤāĻŋāĻšāĻžāϏāĨ¤

Website-verified case numbering: raiyyantahsan.com-āĻāϰ Medical Blog āĻāĻŦāĻ‚ Gynecology archive āϝāĻžāϚāĻžāχ āĻ•āϰ⧇ āϏāĻ°ā§āĻŦāĻļ⧇āώ āĻĒā§āϰāĻ•āĻžāĻļāĻŋāϤ Total Case TC(1372), Department Code 09 āĻāĻŦāĻ‚ Gynecology Case No 46 āĻĒāĻžāĻ“āϝāĻŧāĻž āϗ⧇āϛ⧇āĨ¤ āϏ⧇āχ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻāχ āύāϤ⧁āύ āĻŦā§āϞāϗ⧇āϰ āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āύāĻŽā§āĻŦāϰ TC(1373).(09).Gynecology Department Case No (47)āĨ¤

Prescription reviewed: One handwritten prescription from AMZ Hospital Ltd.

Prescribing consultant: Professor Dr. Jesmine Banu

Specialty: Obstetrics and Gynaecology

Patient: Lipi — āĻ›āĻŦāĻŋāϤ⧇ āĻāχ āύāĻžāĻŽāϟāĻŋ āĻĻ⧇āĻ–āĻž āϝāĻžāĻšā§āϛ⧇āĨ¤

Age: Approximately 39 years

Prescription date: 08 March 2025, as written on the prescription

Review date: Friday, 16 October 2026

Overall clinical interpretation confidence: 0.84/1.00

Important: āĻāχ āĻĒā§āϰāϤāĻŋāĻŦ⧇āĻĻāύāϟāĻŋ āĻĒ⧁āϰ⧋āύ⧋ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ retrospective clinical reviewāĨ¤ āϰ⧋āĻ—ā§€āϰ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āĻ…āĻŦāĻ¸ā§āĻĨāĻž āύāĻž āĻĻ⧇āϖ⧇ āĻāχ āĻ“āώ⧁āϧāϗ⧁āϞ⧋ āύāϤ⧁āύ āĻ•āϰ⧇ āĻļ⧁āϰ⧁ āĻ•āϰāĻž āĻŦāĻž āφāϗ⧇āϰ antibiotic regimen āĻĒ⧁āύāϰāĻžāĻŦ⧃āĻ¤ā§āϤāĻŋ āĻ•āϰāĻž āωāϚāĻŋāϤ āύāϝāĻŧāĨ¤


1. Prescription Overview — āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϏāĻžāϰāϏāĻ‚āĻ•ā§āώ⧇āĻĒ

āĻāχ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻāĻ•āϜāύ gynecological postoperative follow-up āϰ⧋āĻ—ā§€āϕ⧇ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ āĻ•āϰ⧇āϛ⧇āύāĨ¤

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻŽā§‚āϞ clinical issues:

1. Seven days following a gynecological procedure: āĻ¸ā§āĻ¤ā§āϰ⧀-āϰ⧋āĻ—āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻāĻ•āϟāĻŋ āĻĒā§āϰāĻ•ā§āϰāĻŋāϝāĻŧāĻžāϰ āϏāĻžāϤ āĻĻāĻŋāύ āĻĒāϰ āĻĢāϞ⧋āφāĻĒāĨ¤

2. History of cervical erosion: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āχāϰ⧋āĻļāύ⧇āϰ āĻĒā§‚āĻ°ā§āĻŦāχāϤāĻŋāĻšāĻžāϏāĨ¤

3. Lower abdominal/pelvic pain: āϤāϞāĻĒ⧇āϟ āĻŦāĻž āĻļā§āϰ⧋āĻŖāĻŋ āĻ…āĻžā§āϚāϞ⧇ āĻŦā§āϝāĻĨāĻžāĨ¤

4. Mild vaginal bleeding: āϝ⧋āύāĻŋāĻĒāĻĨ⧇ āĻ…āĻ˛ā§āĻĒ āϰāĻ•ā§āϤāĻĒāĻžāϤāĨ¤

5. Possible subclinical hypothyroidism: āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϏāĻžāĻŦāĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻšāĻžāχāĻĒā§‹āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄāĻŋāϜāĻŽāĨ¤

Confidence: 0.86

Corrected Medicine Identification

āφāĻĒāύāĻžāϰ āϏāĻ‚āĻļā§‹āϧāύ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻ›āϝāĻŧāϟāĻŋ āĻ“āώ⧁āϧ⧇āϰ āϏāĻ āĻŋāĻ• āύāĻžāĻŽ āĻ“ generic āĻāĻ–āύ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

No. Correct Brand Name Generic Name Strength Manufacturer
1 Fluclox Flucloxacillin Sodium 500 mg capsule ACI
2 Ornil Ornidazole 500 mg tablet Opsonin Pharma
3 Algin Tiemonium Methylsulfate 50 mg tablet Renata
4 Esonix Esomeprazole 20 mg tablet Incepta
5 Thyrox Levothyroxine Sodium 50 mcg tablet Renata
6 Folix Folinic Acid 5 mg tablet ACME

Medicine identification confidence: 1.00 for user-confirmed medicines 1, 2 and 6; approximately 0.95 for the other three medicines.

āϏāĻŦāĻšā§‡āϝāĻŧ⧇ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āϏāĻ‚āĻļā§‹āϧāύ āĻšāϞ⧋ Folix 5 mg-āĻāϰ generic Folinic Acid, Folic Acid āύāϝāĻŧāĨ¤ MedEx-āĻ āĻ›āϝāĻŧāϟāĻŋ āĻ“āώ⧁āϧ⧇āϰ generic āĻ“ brand information āĻŽāĻŋāϞāĻŋāϝāĻŧ⧇ āĻĻ⧇āĻ–āĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤


2. Definition — āϰ⧋āϗ⧇āϰ āϏāĻ‚āĻœā§āĻžāĻž

Cervical Erosion / Cervical Ectropion

Definition: Cervical ectropion is a benign condition in which endocervical columnar epithelium becomes visible on the outer surface of the cervix.

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āϭ⧇āϤāϰ⧇āϰ āύāϰāĻŽ glandular cells āĻŦāĻžāχāϰ⧇āϰ āĻ…āĻ‚āĻļ⧇ āĻĻ⧇āĻ–āĻž āϝāĻžāĻ“āϝāĻŧāĻžāϕ⧇ cervical ectropion āĻŦāϞāĻž āĻšāϝāĻŧāĨ¤ āφāϗ⧇ āĻāχ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāϕ⧇ āĻĒā§āϰāĻžāϝāĻŧāχ cervical erosion āĻŦāϞāĻž āĻšāϤ⧋āĨ¤

āĻāϤ⧇ āĻ•āĻ–āύ⧋ vaginal discharge, contact bleeding āĻ…āĻĨāĻŦāĻž intercourse-āĻāϰ āĻĒāϰ⧇ spotting āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ cervical ectropion āύāĻŋāĻœā§‡ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻŦāĻž āĻ•ā§āϝāĻžāύāϏāĻžāϰ āύāϝāĻŧāĨ¤

Confidence: 0.98

Postprocedural Pelvic Pain

Definition: Pelvic discomfort occurring after gynecological instrumentation or treatment.

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āĻ– āĻŦāĻž āϜāϰāĻžāϝāĻŧ⧁āϰ āϕ⧋āύ⧋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāĻĻā§āϧāϤāĻŋāϰ āĻĒāϰ⧇ āϤāϞāĻĒ⧇āĻŸā§‡ āĻŦā§āϝāĻĨāĻž āĻšāĻ“āϝāĻŧāĻžāĨ¤

āĻāϰ āĻ•āĻžāϰāĻŖ āĻšāϤ⧇ āĻĒāĻžāϰ⧇ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• healing, uterine cramping, local inflammation āĻ…āĻĨāĻŦāĻž āϕ⧋āύ⧋ postoperative complicationāĨ¤

Subclinical Hypothyroidism

Definition: Serum TSH above the reference range with normal FT4.

āĻŦāĻžāĻ‚āϞāĻž: āϰāĻ•ā§āϤ⧇ TSH āĻŦ⧇āĻĄāĻŧ⧇ āϗ⧇āϞ⧇āĻ“ FT4 āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻĨāĻžāĻ•āĻžāϕ⧇ āϏāĻžāĻŦāĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻšāĻžāχāĻĒā§‹āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄāĻŋāϜāĻŽ āĻŦāϞāĻž āĻšāϝāĻŧāĨ¤

Confidence: 0.99


3. Chief Complaints (C/C) — āĻĒā§āϰāϧāĻžāύ āĻ…āĻ­āĻŋāϝ⧋āĻ—

Doctor's Writing English Interpretation āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ Confidence
7 POD following D&C & EC — probable Seven days after a gynecological procedure āĻ¸ā§āĻ¤ā§āϰ⧀-āϰ⧋āĻ—āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻĒā§āϰāĻ•ā§āϰāĻŋāϝāĻŧāĻžāϰ āϏāĻžāϤ āĻĻāĻŋāύ āĻĒāϰ 0.78
Pelv. abd. pain Pelvic/lower abdominal pain āϤāϞāĻĒ⧇āĻŸā§‡ āĻŦā§āϝāĻĨāĻž 0.94
F/U Follow-up āĻĢāϞ⧋āφāĻĒ⧇ āĻāϏ⧇āϛ⧇āύ 0.97
V/B — 2 days (mild) Mild vaginal bleeding for two days āĻĻ⧁āχ āĻĻāĻŋāύ āϧāϰ⧇ āĻ…āĻ˛ā§āĻĒ āϝ⧋āύāĻŋāĻĒāĻĨ⧇ āϰāĻ•ā§āϤāĻĒāĻžāϤ 0.90

Clinical significance

Postoperative pain and mild bleeding āĻ…āύ⧇āĻ• āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• recovery-āϰ āĻ…āĻ‚āĻļ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ āĻŦā§āϝāĻĨāĻž āĻŦ⧇āĻĄāĻŧ⧇ āϝāĻžāĻ“āϝāĻŧāĻž, āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āϰāĻ•ā§āϤāĻĒāĻžāϤ, āĻœā§āĻŦāϰ āĻŦāĻž āĻĻ⧁āĻ°ā§āĻ—āĻ¨ā§āϧāϝ⧁āĻ•ā§āϤ āĻ¸ā§āϰāĻžāĻŦ āĻĨāĻžāĻ•āϞ⧇ postoperative infection āĻŦāĻž āĻ…āĻ¨ā§āϝ complication āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāϝāĻŧāĨ¤

Confidence: 0.96


4. Menstrual History (M/H) — āĻŽāĻžāϏāĻŋāϕ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ

History English āĻŦāĻžāĻ‚āϞāĻž Confidence
MP: 7/3/25 — probable Menstrual period date āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻŽāĻžāϏāĻŋāϕ⧇āϰ āϤāĻžāϰāĻŋāĻ– ā§­ āĻŽāĻžāĻ°ā§āϚ ⧍ā§Ļ⧍ā§Ģ 0.70
MC: R/4–5 days Regular menstruation, duration 4–5 days āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻŽāĻžāϏāĻŋāĻ•, āϏāĻžāϧāĻžāϰāĻŖāϤ ā§Ē–ā§Ģ āĻĻāĻŋāύ 0.90
F: Avg Average menstrual flow āĻŽāĻžāĻāĻžāϰāĻŋ āϰāĻ•ā§āϤāĻĒāĻžāϤ 0.95
S: −ve Negative symptom marker, exact meaning unclear āĻāĻ•āϟāĻŋ āωāĻĒāϏāĻ°ā§āĻ— āĻ…āύ⧁āĻĒāĻ¸ā§āĻĨāĻŋāϤ; āϏāĻ‚āĻ•ā§āώāĻŋāĻĒā§āϤ āϰ⧂āĻĒ āĻ…āĻ¸ā§āĻĒāĻˇā§āϟ 0.50

Clinical note: āĻŽāĻžāϏāĻŋāϕ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āĻĨ⧇āϕ⧇ āϕ⧋āύ⧋ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ menstrual disorder āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžāϝāĻŧ āύāĻžāĨ¤


5. Obstetric History (O/H) — āĻĒā§āϰāϏ⧂āϤāĻŋ āχāϤāĻŋāĻšāĻžāϏ

Prescription Note Interpretation āĻŦāĻžāĻ‚āϞāĻž
3 NVD Three normal vaginal deliveries āϤāĻŋāύāĻŦāĻžāϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻĒā§āϰāϏāĻŦ
+0 Possibly no abortion history āϏāĻŽā§āĻ­āĻŦāϤ āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āύ⧇āχ; āύāĻŋāĻļā§āϚāĻŋāϤāĻ•āϰāĻŖ āĻĒā§āϰāϝāĻŧā§‹āϜāύ
F: 22 yrs First childbirth-related entry, interpretation uncertain āĻĒā§āϰāĻĨāĻŽ āϏāĻ¨ā§āϤāĻžāύāϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ ⧍⧍ āĻŦāĻ›āϰ⧇āϰ āĻāĻ•āϟāĻŋ āϤāĻĨā§āϝ
LC: 12 yrs Last child approximately 12 years āϏāĻ°ā§āĻŦāĻļ⧇āώ āϏāĻ¨ā§āϤāĻžāύ⧇āϰ āĻŦāϝāĻŧāϏ āϏāĻŽā§āĻ­āĻŦāϤ ⧧⧍ āĻŦāĻ›āϰ

Provisional obstetric history: G3P3 āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āĻ•āĻŋāĻ¨ā§āϤ⧁ āĻĒā§‚āĻ°ā§āĻŖ gravidity āĻ“ abortion history āύāĻŋāĻļā§āϚāĻŋāϤ āύāϝāĻŧāĨ¤

Confidence: 0.85

Drug History (D/H)

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ Thyrox 50 mcg āϰāϝāĻŧ⧇āϛ⧇āĨ¤ āĻāϟāĻŋ āφāϗ⧇ āĻĨ⧇āϕ⧇ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāĻšā§āĻ›āĻŋāϞ, āύāĻžāĻ•āĻŋ āύāϤ⧁āύ āĻ•āϰ⧇ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇āĻ›ā§‡â€”āϏ⧇āϟāĻŋ āύāĻŋāĻļā§āϚāĻŋāϤ āύāϝāĻŧāĨ¤

Allergy history: Not documented.


6. Physical Examination, Doctor's Dx, Investigations and Advice

O/S/E — On Systemic Examination

Parameter Prescription Finding āĻŦāĻžāĻ‚āϞāĻž
Blood pressure Approximately 100/80 mmHg āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϰāĻ•ā§āϤāϚāĻžāĻĒ ā§§ā§Ļā§Ļ/ā§Žā§Ļ
Body weight Approximately 84 kg āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ“āϜāύ ā§Žā§Ē āϕ⧇āϜāĻŋ
Pulse Not documented clearly āĻ¸ā§āĻĒāĻˇā§āϟ āϞ⧇āĻ–āĻž āύ⧇āχ
Temperature Not documented āϞ⧇āĻ–āĻž āύ⧇āχ
BMI Cannot determine āωāĻšā§āϚāϤāĻž āύāĻž āĻĨāĻžāĻ•āĻžāϝāĻŧ āĻšāĻŋāϏāĻžāĻŦ āĻ•āϰāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻž

Confidence: 0.88 for visible findings.

O/E — General Examination

Pallor, edema, abdominal tenderness āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ general examination findings āĻ¸ā§āĻĒāĻˇā§āϟāĻ­āĻžāĻŦ⧇ āύāĻĨāĻŋāϭ⧁āĻ•ā§āϤ āύ⧇āχāĨ¤

O/G/E — Obstetric and Gynecological Examination

Speculum examination, cervical appearance, uterine tenderness, cervical motion tenderness āĻ…āĻĨāĻŦāĻž adnexal findings āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝāĻ­āĻžāĻŦ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧāύāĻŋāĨ¤

Clinical significance: āĻāϏāĻŦ āϤāĻĨā§āϝ āĻ›āĻžāĻĄāĻŧāĻž postoperative infection āύāĻŋāĻļā§āϚāĻŋāϤ āĻŦāĻž āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻžāĻĻ āĻĻ⧇āĻ“āϝāĻŧāĻž āϏāĻŽā§āĻ­āĻŦ āύāϝāĻŧāĨ¤

Doctor's Diagnosis (Dx)

āωāĻĒāϰ⧇āϰ handwritten note āĻĨ⧇āϕ⧇ āύāĻŋāĻŽā§āύāϞāĻŋāĻ–āĻŋāϤ āĻŦāĻŋāώāϝāĻŧāϗ⧁āϞ⧋ āĻŦā§‹āĻāĻž āϝāĻžāϝāĻŧ:

1. Seven days postoperative following a gynecological procedure.

āĻŦāĻžāĻ‚āϞāĻž: āĻ¸ā§āĻ¤ā§āϰ⧀-āϰ⧋āĻ—āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāĻĻā§āϧāϤāĻŋāϰ āϏāĻžāϤ āĻĻāĻŋāύ āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāĨ¤

2. History of cervical erosion.

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āχāϰ⧋āĻļāύ⧇āϰ āĻĒā§‚āĻ°ā§āĻŦāχāϤāĻŋāĻšāĻžāϏāĨ¤

3. Possible SCH — Subclinical Hypothyroidism.

āĻŦāĻžāĻ‚āϞāĻž: āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϏāĻžāĻŦāĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻšāĻžāχāĻĒā§‹āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄāĻŋāϜāĻŽāĨ¤

4. Previous history of three normal vaginal deliveries.

āĻŦāĻžāĻ‚āϞāĻž: āĻĒā§‚āĻ°ā§āĻŦ⧇ āϤāĻŋāύāĻŦāĻžāϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻĒā§āϰāϏāĻŦ āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

Doctor's Dx transcription confidence: 0.80

Investigations Prescribed

āĻāχ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āύāϤ⧁āύ āĻ•āϰ⧇ āϕ⧋āύ⧋ investigation āĻ¸ā§āĻĒāĻˇā§āϟāĻ­āĻžāĻŦ⧇ āϞ⧇āĻ–āĻž āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧāύāĻŋāĨ¤

Documented investigations: None clearly identifiable.

Doctor's Advice

“HPV vaccine — 3 doses complete.”

āĻŦāĻžāĻ‚āϞāĻž: HPV vaccine-āĻāϰ āϤāĻŋāύ āĻĄā§‹āϜ āϏāĻŽā§āĻĒāĻ¨ā§āύ āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

āĻāϟāĻŋ vaccination history āĻšāĻŋāϏ⧇āĻŦ⧇ āϞ⧇āĻ–āĻž āĻšāϝāĻŧ⧇āϛ⧇ āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāĻšā§āϛ⧇; āύāϤ⧁āύ āϤāĻŋāύ āĻĄā§‹āϜ āύ⧇āĻ“āϝāĻŧāĻžāϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āύāϝāĻŧāĨ¤

Confidence: 0.95


🟩 7. Prescribed Drug Analysis — MedEx āĻ…āύ⧁āϝāĻžāϝāĻŧā§€

7.1 Original Prescription: Corrected Medicine Audit

No. Original Medicine Prescription Dose — Apparent Drug Category Main Purpose
1 Cap. Fluclox 500 mg 1+1+1; duration unclear Penicillin antibiotic Suspected susceptible bacterial infection
2 Tab. Ornil 500 mg 1+1+1; approximately 5 days Nitroimidazole antimicrobial Possible anaerobic/protozoal infection
3 Tab. Algin 50 mg 1+1+1 Antispasmodic Pelvic spasm/pain
4 Tab. Esonix 20 mg 1+0+1 PPI Gastric acid suppression
5 Tab. Thyrox 50 mcg 1+0+0 Thyroid hormone Hypothyroidism management
6 Tab. Folix 5 mg 0+1+0 Folinic acid preparation Folate-related indication, not established

Important prescription safety finding: Fluclox āĻāĻŦāĻ‚ Ornil-āĻāϰ āĻšāĻžāϤ⧇ āϞ⧇āĻ–āĻž frequency 1+1+1 āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāĻšā§āϛ⧇āĨ¤ āĻ•āĻŋāĻ¨ā§āϤ⧁ āĻāχ dosing pattern āϰ⧋āĻ—, āĻœā§€āĻŦāĻžāϪ⧁ āĻ“ treatment indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āϜāϰ⧁āϰāĻŋāĨ¤ āύāĻŋāĻšā§‡ MedEx-āĻāϰ standard doses-āĻāϰ āϏāĻ™ā§āϗ⧇ āϤ⧁āϞāύāĻž āĻ•āϰāĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤ āĻāϟāĻŋ āφāϗ⧇āϰ prescription āĻ…āύ⧁āϏāϰāĻŖ āĻ•āϰāĻžāϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āύāϝāĻŧāĨ¤


Medicine 1 — Cap. Fluclox 500 mg

1. Generic Name

Flucloxacillin Sodium — āĻĢā§āϞ⧁āĻ•ā§āϞāĻ•ā§āϏāĻžāϏāĻŋāϞāĻŋāύ āϏ⧋āĻĄāĻŋāϝāĻŧāĻžāĻŽāĨ¤

2. Brand Name

Fluclox 500 mg Capsule

Manufacturer: Advanced Chemical Industries PLC (ACI).

3. MedEx Alternative Brands

A-Flox, Adflox, Ancoc āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ Flucloxacillin brandsāĨ¤

4. MedEx Therapeutic Class

Narrow Spectrum Penicillin.

5. Pharmacological Class

Beta-lactam antibiotic; penicillinase-resistant isoxazolyl penicillin.

āĻŦāĻžāĻ‚āϞāĻž: āĻĒ⧇āύāĻŋāϏāĻŋāϞāĻŋāύ-āϜāĻžāϤ⧀āϝāĻŧ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻžāύāĻžāĻļāĻ• āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻžāϝāĻŧā§‹āϟāĻŋāĻ•āĨ¤

6. Use/Purpose of Drug

Gram-positive bacterial infections, āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ susceptible staphylococcal infection-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

7. Why Doctor Prescribed This Drug in This Patient

Possible reason: Gynecological procedure-āĻāϰ āĻĒāϰ⧇ susceptible bacterial infection āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻŦāĻž āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻžāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĨāĻžāĻ•āϞ⧇ āĻ…āĻĨāĻŦāĻž āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻŦāĻŋāĻŦ⧇āϚāύāĻžāϝāĻŧ āϤāĻžāϰ āĻā§āρāĻ•āĻŋ āĻĨāĻžāĻ•āϞ⧇ āĻāχ antibiotic āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āĻļ⧁āϧ⧁ postoperative āĻ…āĻŦāĻ¸ā§āĻĨāĻž āĻĨ⧇āϕ⧇ antibiotic indication āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžāϝāĻŧ āύāĻžāĨ¤

Patient-specific rationale confidence: 0.65

8. Side Effects

Nausea, vomiting, diarrhea, skin rash, urticaria āĻāĻŦāĻ‚ rare cholestatic hepatitisāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻŦāĻŽāĻŋāĻ­āĻžāĻŦ, āĻĄāĻžāϝāĻŧāϰāĻŋāϝāĻŧāĻž, āĻ¤ā§āĻŦāϕ⧇ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻ“ āĻŦāĻŋāϰāϞ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϝāĻ•ā§ƒāϤ⧇āϰ āĻ•ā§āώāϤāĻŋāĨ¤

9. MedEx Link

Fluclox 500 mg — MedEx

10. Unit Price, Strip Price and Other Composition

Unit price: ā§ŗ14.00

Strip price: ā§ŗ140.00 (10 capsules)

Other formulations include 250 mg capsule, 125 mg/5 mL and 250 mg/5 mL oral suspension, and injectable preparations.

11. Mechanism of Action

Flucloxacillin inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins and interfering with peptidoglycan cross-linking.

āĻŦāĻžāĻ‚āϞāĻž: āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻžāϰ cell wall āϤ⧈āϰāĻŋ āĻŦāĻ¨ā§āϧ āĻ•āϰ⧇ āĻœā§€āĻŦāĻžāϪ⧁ āĻ§ā§āĻŦāĻ‚āϏ āĻ•āϰ⧇āĨ¤

12. Drug Indications

Skin and soft-tissue infections, infected wounds, cellulitis, abscesses, susceptible respiratory infections, osteomyelitis āĻāĻŦāĻ‚ selected other infections caused by susceptible organismsāĨ¤

13. Drug Interactions and Contraindications

Contraindication: Penicillin hypersensitivityāĨ¤

Interactions: Probenecid flucloxacillin level āĻŦāĻžāĻĄāĻŧāĻžāϤ⧇ āĻĒāĻžāϰ⧇; methotrexate-āĻāϰ clearance āĻĒā§āϰāĻ­āĻžāĻŦāĻŋāϤ āĻšāĻ“āϝāĻŧāĻžāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

14. Precautions and Warnings

Previous penicillin allergy, hepatic dysfunction āĻāĻŦāĻ‚ renal impairment āĻĨāĻžāĻ•āϞ⧇ āϏāϤāĻ°ā§āĻ•āϤāĻž āϜāϰ⧁āϰāĻŋāĨ¤

15. Dosage and Administration

MedEx-āĻ āϏāĻžāϧāĻžāϰāĻŖ adult oral dose āĻšāĻŋāϏ⧇āĻŦ⧇ 250 mg four times daily āωāĻ˛ā§āϞ⧇āĻ– āφāϛ⧇; infection severity āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ dose adjustment āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻ–āĻžāĻŦāĻžāϰ⧇āϰ āĻāĻ• āϘāĻŖā§āϟāĻž āφāϗ⧇ āύ⧇āĻ“āϝāĻŧāĻžāϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āϰāϝāĻŧ⧇āϛ⧇āĨ¤

Prescription shows: āϏāĻŽā§āĻ­āĻŦāϤ 500 mg āϤāĻŋāύāĻŦāĻžāϰ āĻĻ⧈āύāĻŋāĻ•āĨ¤ āĻāϟāĻŋ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻ“ indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ prescriber-āĻāϰ āϏāĻ™ā§āϗ⧇ āϝāĻžāϚāĻžāχāϝ⧋āĻ—ā§āϝāĨ¤

16. Pregnancy and Lactation

Pregnancy-āϤ⧇ āĻ¸ā§āĻĒāĻˇā§āϟ indication āĻĨāĻžāĻ•āϞ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ benefit–risk assessment āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝāĻžāϝāĻŧāĨ¤ Breast milk-āĻ āĻ…āĻ˛ā§āĻĒ āĻĒāϰāĻŋāĻŽāĻžāĻŖ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇; nursing infant-āĻ diarrhea, thrush āĻŦāĻž allergy āĻĒāĻ°ā§āϝāĻŦ⧇āĻ•ā§āώāĻŖ āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤

Clinical confidence: 0.98 for verified pharmacology; 0.65 for patient-specific indication.


Medicine 2 — Tab. Ornil 500 mg

1. Generic Name

Ornidazole — āĻ…āĻ°ā§āύāĻŋāĻĄāĻžāϜāϞāĨ¤

2. Brand Name

Ornil 500 mg Tablet

Manufacturer: Opsonin Pharma Ltd.

3. MedEx Alternative Brands

Ornid, Ornizol, Robic, Troniz āĻāĻŦāĻ‚ XynorāĨ¤

4. MedEx Therapeutic Class

Amoebicides, Anti-diarrhoeal Antiprotozoal.

5. Pharmacological Class

5-Nitroimidazole antimicrobial — Antiprotozoal and anti-anaerobic agent.

6. Use/Purpose of Drug

Anaerobic bacterial infection āĻāĻŦāĻ‚ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ protozoal infection-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĨ¤

7. Why Doctor Prescribed This Drug in This Patient

Possible reason: Postprocedural anaerobic infection coverage āĻ…āĻĨāĻŦāĻž vaginal infection-āĻāϰ āϏāĻ¨ā§āĻĻ⧇āĻšā§‡ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āĻĒāϰ⧇ āĻ•āĻŋāϛ⧁ anaerobic āĻœā§€āĻŦāĻžāϪ⧁āϰ āĻŦāĻŋāϰ⧁āĻĻā§āϧ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĻ⧇āĻ“āϝāĻŧāĻžāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āϰ⧋āĻ—ā§€āϰ bacterial vaginosis, trichomoniasis āĻŦāĻž pelvic infection āύāĻŋāĻļā§āϚāĻŋāϤ āĻšāĻ“āϝāĻŧāĻžāϰ āϕ⧋āύ⧋ test āĻŦāĻž examination finding āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧāύāĻŋāĨ¤

Patient-specific rationale confidence: 0.65

8. Side Effects

Nausea, vomiting, abdominal pain, dizziness, headache, drowsiness āĻāĻŦāĻ‚ rare leukopeniaāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻŦāĻŽāĻŋāĻ­āĻžāĻŦ, āĻĒ⧇āϟāĻŦā§āϝāĻĨāĻž, āĻŽāĻžāĻĨāĻž āĻ˜ā§‹āϰāĻž, āĻŽāĻžāĻĨāĻžāĻŦā§āϝāĻĨāĻž āĻāĻŦāĻ‚ āĻŦāĻŋāϰāϞ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻļā§āĻŦ⧇āϤ āϰāĻ•ā§āϤāĻ•āĻŖāĻŋāĻ•āĻž āĻ•āĻŽā§‡ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

9. MedEx Link

Ornil 500 mg — MedEx

10. Unit Price, Strip Price and Composition

Unit price: ā§ŗ7.00

Strip price: ā§ŗ70.00 (10 tablets)

Available alternative brands use the same Ornidazole 500 mg composition.

11. Mechanism of Action

Ornidazole undergoes intracellular reduction in susceptible organisms. Its reactive metabolites damage microbial DNA.

āĻŦāĻžāĻ‚āϞāĻž: āĻœā§€āĻŦāĻžāϪ⧁āϰ DNA āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰ⧇ āĻœā§€āĻŦāĻžāϪ⧁ āĻ§ā§āĻŦāĻ‚āϏ āĻ•āϰ⧇āĨ¤

12. Drug Indications

â€ĸ Bacterial vaginosisāĨ¤

â€ĸ TrichomoniasisāĨ¤

â€ĸ AmoebiasisāĨ¤

â€ĸ GiardiasisāĨ¤

â€ĸ Susceptible anaerobic bacterial infectionsāĨ¤

13. Drug Interactions and Contraindications

Interactions: Oral anticoagulants-āĻāϰ āϏāĻ™ā§āϗ⧇ bleeding risk āĻŦāĻžāĻĄāĻŧāϤ⧇ āĻĒāĻžāϰ⧇; 5-fluorouracil-āĻāϰ clearance āĻĒā§āϰāĻ­āĻžāĻŦāĻŋāϤ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Contraindications: Nitroimidazole hypersensitivity āĻāĻŦāĻ‚ MedEx āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻ•āĻŋāϛ⧁ central/peripheral neurological disordersāĨ¤

14. Precautions and Warnings

Vertigo, ataxia, confusion, neurological symptoms, severe hepatic dysfunction āĻ…āĻĨāĻŦāĻž prolonged therapy-āϤ⧇ āϏāϤāĻ°ā§āĻ•āϤāĻžāĨ¤

15. Dosage and Administration

MedEx-āĻāϰ examples:

Trichomoniasis: 500 mg twice daily for five days āĻ…āĻĨāĻŦāĻž indication-specific alternative regimenāĨ¤

Bacterial vaginosis: MedEx-āĻāϰ Ornil monograph-āĻ 500 mg once daily for five to seven days-āϏāĻš āĻ•āĻŋāϛ⧁ regimen āωāĻ˛ā§āϞ⧇āĻ– āφāϛ⧇āĨ¤

Prescription: 500 mg āϤāĻŋāύāĻŦāĻžāϰ āĻĻ⧈āύāĻŋāĻ• āϞ⧇āĻ–āĻž āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāĻšā§āϛ⧇āĨ¤ āĻāϟāĻŋ āωāĻĒāϰ⧋āĻ•ā§āϤ āϏāĻžāϧāĻžāϰāĻŖ regimen āĻĨ⧇āϕ⧇ āĻ­āĻŋāĻ¨ā§āύ; original indication āĻāĻŦāĻ‚ frequency āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϜāϰ⧁āϰāĻŋāĨ¤

CDC-āĻāϰ BV āĻ“ PID guidelines-āĻ routinely recommended antimicrobial regimens Ornidazole-āĻ­āĻŋāĻ¤ā§āϤāĻŋāĻ• āύāϝāĻŧāĨ¤ āĻĢāϞ⧇ Ornil-āĻāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āφāϰ guideline-recommended metronidazole regimen-āϕ⧇ āĻ¸ā§āĻŦāϝāĻŧāĻ‚āĻ•ā§āϰāĻŋāϝāĻŧāĻ­āĻžāĻŦ⧇ āĻāĻ• āĻŦāϞ⧇ āϧāϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

16. Pregnancy and Lactation

Pregnancy āĻāĻŦāĻ‚ breastfeeding-āĻ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ clinical safety evidence āϏ⧀āĻŽāĻŋāϤ; āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ indication āĻ“ risk assessment āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤

Clinical confidence: 0.98 for verified pharmacology; 0.65 for patient's indication.


Medicine 3 — Tab. Algin 50 mg

1. Generic Name

Tiemonium Methylsulfate — āϟāĻžāχāĻŽā§‹āύāĻŋāϝāĻŧāĻžāĻŽ āĻŽāĻŋāĻĨāĻžāχāϞāϏāĻžāϞāĻĢ⧇āϟāĨ¤

2. Brand Name

Algin 50 mg Tablet

Manufacturer: Renata PLC.

3. MedEx Alternative Brands

Aspasom, Deltimo, Dysma āĻāĻŦāĻ‚ EmogināĨ¤

4. MedEx Therapeutic Class

Anticholinergics.

5. Pharmacological Class

Anticholinergic antispasmodic.

6. Use/Purpose

Uterine, intestinal, biliary āĻāĻŦāĻ‚ urinary tract smooth-muscle spasm āĻ•āĻŽāĻžāύ⧋āĨ¤

7. Why Doctor Prescribed This Drug in This Patient

Likely purpose: Lower abdominal/pelvic cramping āĻ•āĻŽāĻžāύ⧋āĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžāϝāĻŧ⧁ āĻŦāĻž āϤāϞāĻĒ⧇āĻŸā§‡āϰ āĻĒ⧇āĻļāĻŋāϰ āĻ–āĻŋāρāϚ⧁āύāĻŋāϜāύāĻŋāϤ āĻŦā§āϝāĻĨāĻž āĻ•āĻŽāĻžāϤ⧇ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Confidence: 0.90

8. Side Effects

Tachycardia, hypotension, dry mouth āĻ…āĻĨāĻŦāĻž visual disturbance āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

9. MedEx Link

Algin 50 mg — MedEx

10. Unit Price, Strip Price and Composition

Unit price: ā§ŗ8.50

Strip price: ā§ŗ85.00 (10 tablets)

Other forms: syrup 10 mg/5 mL āĻāĻŦāĻ‚ injection 5 mg/2 mLāĨ¤

11. Mechanism

Anticholinergic action-āĻāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ visceral smooth muscle contraction āĻ•āĻŽāĻžāϝāĻŧāĨ¤

12. Indications

Functional intestinal, biliary, urinary āĻāĻŦāĻ‚ gynecological spasm-related paināĨ¤

13. Interactions and Contraindications

Other anticholinergics-āĻāϰ āϏāĻ™ā§āϗ⧇ additive adverse effects āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Contraindications: Angle-closure glaucoma risk āĻāĻŦāĻ‚ urinary retention riskāĨ¤

14. Precautions

Cardiovascular disease, renal/hepatic impairment āĻāĻŦāĻ‚ visual disturbances-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāϤāĻ°ā§āĻ•āϤāĻžāĨ¤

15. Dosage and Administration

MedEx āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ usual adult oral dosage 2–6 tablets daily in divided dosesāĨ¤

Prescription-āĻ āϏāĻŽā§āĻ­āĻŦāϤ 1+1+1 āϞ⧇āĻ–āĻž āϰāϝāĻŧ⧇āϛ⧇āĨ¤

16. Pregnancy and Lactation

Pregnancy-āϤ⧇ benefit–risk review āĻāĻŦāĻ‚ breastfeeding-āĻ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ safety data āύāĻž āĻĨāĻžāĻ•āĻžāϝāĻŧ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤

Clinical confidence: 0.97


Medicine 4 — Tab. Esonix 20 mg

1. Generic Name

Esomeprazole — āχāϏ⧋āĻŽāĻŋāĻĒā§āϰāĻžāϜāϞāĨ¤

2. Brand Name

Esonix 20 mg EC Tablet

Manufacturer: Incepta Pharmaceuticals Ltd.

3. MedEx Alternative Brands

Esoral, Esopra āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ Esomeprazole brandsāĨ¤

4. MedEx Therapeutic Class

Proton Pump Inhibitor.

5. Pharmacological Class

Gastric Hâē/Kâē-ATPase inhibitorāĨ¤

6. Use/Purpose

Gastric acid secretion āĻ•āĻŽāĻžāύ⧋āĨ¤

7. Why Doctor Prescribed This Drug in This Patient

Possible purpose: Gastric symptoms āĻŦāĻž acid-related discomfort controlāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āĻ—ā§āϝāĻžāĻ¸ā§āĻŸā§āϰāĻŋāĻ• āĻ…ā§āϝāĻžāϏāĻŋāĻĄ āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ GERD āĻŦāĻž ulcer-āĻāϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ diagnosis āϞ⧇āĻ–āĻž āύ⧇āχāĨ¤

Confidence: 0.65

8. Side Effects

Headache, diarrhea, nausea, abdominal discomfort āĻāĻŦāĻ‚ constipationāĨ¤

9. MedEx Link

Esonix 20 mg — MedEx

10. Unit Price, Strip Price and Composition

Unit price: ā§ŗ7.00

Strip price: ā§ŗ98.00 (14 tablets)

Other forms: 40 mg tablets, 20/40 mg capsules, injection āĻāĻŦāĻ‚ powderāĨ¤

11. Mechanism

Gastric parietal cell-āĻāϰ proton pump block āĻ•āϰ⧇ gastric acid production āĻ•āĻŽāĻžāϝāĻŧāĨ¤

12. Indications

GERD, erosive esophagitis, acid-related dyspepsia, peptic ulcer disease āĻāĻŦāĻ‚ selected H. pylori regimensāĨ¤

13. Interactions and Contraindications

Clopidogrel-āĻāϰ antiplatelet effect āĻ•āĻŽāĻžāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ•āĻŋāϛ⧁ antiretroviral medicine āĻāĻŦāĻ‚ pH-dependent absorption drugs-āĻāϰ āϏāĻ™ā§āϗ⧇ interaction āĻšāϝāĻŧāĨ¤

Known hypersensitivity-āϤ⧇ contraindicatedāĨ¤

14. Precautions

Long-term use-āĻ hypomagnesemia, vitamin B12 deficiency, kidney injury āĻāĻŦāĻ‚ infection-related concerns āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

15. Dosage

āĻ…āύ⧇āĻ• GERD/acid-related indication-āĻ 20 mg once daily āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧāĨ¤

Prescription-āĻ āϏāĻŽā§āĻ­āĻŦāϤ 1+0+1āĨ¤ āĻāχ twice-daily schedule-āĻāϰ indication āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āĻĻāϰāĻ•āĻžāϰāĨ¤

16. Pregnancy and Lactation

Pregnancy āĻŦāĻž breastfeeding-āĻ clinical indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ benefit–risk assessment āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤

Clinical confidence: 0.98 for pharmacology; 0.65 for patient-specific rationale.


Medicine 5 — Tab. Thyrox 50 mcg

1. Generic Name

Levothyroxine Sodium — āϞāĻŋāĻ­ā§‹āĻĨāĻžāχāϰāĻ•ā§āϏāĻŋāύ āϏ⧋āĻĄāĻŋāϝāĻŧāĻžāĻŽāĨ¤

2. Brand Name

Thyrox 50 mcg Tablet

Manufacturer: Renata PLC.

3. MedEx Alternative Brands

Euthycin, Euthyrox, Leroid āĻāĻŦāĻ‚ ThyronorāĨ¤

4. MedEx Therapeutic Class

Thyroid Hormones.

5. Pharmacological Class

Synthetic thyroid hormone T4 replacementāĨ¤

6. Use/Purpose

Hypothyroidism treatmentāĨ¤

7. Why Doctor Prescribed This Drug in This Patient

Possible history of subclinical āĻŦāĻž established hypothyroidismāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϰ⧋āĻ—ā§€āϰ āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄ āĻšāϰāĻŽā§‹āύ⧇āϰ āϘāĻžāϟāϤāĻŋ āĻĨāĻžāĻ•āϞ⧇ āϤāĻž āĻĒā§‚āϰāϪ⧇āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ TSH āĻāĻŦāĻ‚ FT4 āϰāĻŋāĻĒā§‹āĻ°ā§āϟ āύāĻž āĻĨāĻžāĻ•āĻžāϝāĻŧ SCH āύāĻŋāĻļā§āϚāĻŋāϤ āύāϝāĻŧāĨ¤

Confidence: 0.70

8. Side Effects

Excessive dose-āĻ palpitations, tachycardia, tremor, sweating, anxiety āĻāĻŦāĻ‚ insomniaāĨ¤

9. MedEx Link

Thyrox 50 mcg — MedEx

10. Unit Price, Strip Price and Other Composition

Unit price: ā§ŗ2.20

30 tablets-āĻāϰ āĻŽā§‚āĻ˛ā§āϝ: ā§ŗ66.00

90-tablet pack: ā§ŗ198.00

Other strengths: 25, 75 āĻāĻŦāĻ‚ 100 mcg tabletsāĨ¤

11. Mechanism

Levothyroxine synthetic T4 āĻšāĻŋāϏ⧇āĻŦ⧇ āĻ•āĻžāϜ āĻ•āϰ⧇āĨ¤ Peripheral tissues-āĻ āĻ•āĻŋāϛ⧁ T4, active T3-āϤ⧇ convert āĻšāϝāĻŧāĨ¤

12. Indications

Primary hypothyroidism, selected secondary hypothyroidism āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ thyroid-related suppression indicationsāĨ¤

13. Interactions and Contraindications

Calcium, iron, antacids āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ acid-suppressing medicines levothyroxine absorption āĻĒā§āϰāĻ­āĻžāĻŦāĻŋāϤ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Contraindications: Untreated thyrotoxicosis āĻāĻŦāĻ‚ uncorrected adrenal insufficiencyāĨ¤

14. Precautions

Cardiac disease, arrhythmia, pregnancy āĻāĻŦāĻ‚ dose changes-āĻāϰ āϏāĻŽāϝāĻŧ TSH/FT4 monitoring āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

15. Dosage and Administration

Prescription-āĻ āϏāĻŽā§āĻ­āĻŦāϤ 50 mcg once dailyāĨ¤

āϏāĻžāϧāĻžāϰāĻŖāϤ āϏāĻ•āĻžāϞ⧇ āĻ–āĻžāϞāĻŋ āĻĒ⧇āĻŸā§‡ āĻ–āĻžāĻŦāĻžāϰ⧇āϰ 30–60 āĻŽāĻŋāύāĻŋāϟ āφāϗ⧇ āύ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧāĨ¤ Iron/calcium āĻĨ⧇āϕ⧇ āĻ…āĻ¨ā§āϤāϤ āϚāĻžāϰ āϘāĻŖā§āϟāĻžāϰ āĻŦā§āϝāĻŦāϧāĻžāύ āϰāĻžāĻ–āĻž āωāϚāĻŋāϤāĨ¤

Dose TSH āĻāĻŦāĻ‚ FT4 āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

16. Pregnancy and Lactation

Hypothyroidism āĻĨāĻžāĻ•āϞ⧇ pregnancy-āϤ⧇ levothyroxine treatment āĻŦāĻŋāĻļ⧇āώāĻ­āĻžāĻŦ⧇ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤ Breastfeeding-āĻ āϏāĻžāϧāĻžāϰāĻŖ replacement therapy compatibleāĨ¤

Clinical confidence: 0.99 for drug information; 0.70 for patient's thyroid diagnosis.


Medicine 6 — Tab. Folix 5 mg

1. Generic Name

Folinic Acid — āĻĢāϞāĻŋāύāĻŋāĻ• āĻ…ā§āϝāĻžāϏāĻŋāĻĄāĨ¤

Also known as Calcium Folinate / LeucovorināĨ¤

Important: Folix 5 mg is NOT ordinary Folic Acid 5 mg.

2. Brand Name

Folix 5 mg Tablet

Manufacturer: ACME Laboratories Ltd.

3. MedEx Alternative Brands

Actifol, Biofol, Folidel, Folimax, Folinic āĻāĻŦāĻ‚ FolitaāĨ¤

4. MedEx Therapeutic Class

Supportive Care Therapy.

5. Pharmacological Class

Reduced folate derivative / Folate rescue agent.

6. Use/Purpose

Folate-antagonist toxicity management, selected megaloblastic anemia āĻāĻŦāĻ‚ certain oncology protocolsāĨ¤

7. Why Doctor Prescribed This Drug in This Patient

Possible purpose: Folate-related deficiency āĻŦāĻž hematological supportāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϕ⧋āύ⧋ folate-related deficiency āĻŦāĻž anemia-related indication āĻĨāĻžāĻ•āϞ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ anemia diagnosis, CBC, vitamin B12 āĻŦāĻž folate assay āύ⧇āχāĨ¤

āϤāĻžāχ āĻāχ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ Folix āĻĻ⧇āĻ“āϝāĻŧāĻžāϰ āϏ⧁āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ•āĻžāϰāĻŖ āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻŋāϤ āύāϝāĻŧāĨ¤

Patient-specific rationale confidence: 0.45

8. Side Effects

Hypersensitivity āĻāĻŦāĻ‚ gastrointestinal effects āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ Chemotherapy-associated regimens-āĻ mucositis, stomatitis, diarrhea āĻ“ hematological adverse events āĻĻ⧇āĻ–āĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇, āϤāĻŦ⧇ āϏāĻŦāϗ⧁āϞ⧋āϕ⧇ low-dose Folix-āĻāϰ āύāĻŋāϜāĻ¸ā§āĻŦ āĻĒā§āϰāĻ­āĻžāĻŦ āĻŦāϞāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

9. MedEx Link

Folix 5 mg — MedEx

10. Unit Price, Strip Price and Other Composition

Unit price: ā§ŗ9.00

Strip price: ā§ŗ90.00 (10 tablets)

Also available as Folix 15 mg tabletāĨ¤

11. Mechanism of Action

Folinic acid āĻšāϞ⧋ biologically active reduced folate derivativeāĨ¤ āĻāϟāĻŋ purine āĻāĻŦāĻ‚ thymidylate synthesis-āĻ āϏāĻšāĻžāϝāĻŧāϤāĻž āĻ•āϰ⧇ āĻāĻŦāĻ‚ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ folate-antagonist toxicity-āϤ⧇ normal cells rescue āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

12. Drug Indications

â€ĸ Methotrexate rescueāĨ¤

â€ĸ Selected folate-antagonist toxicityāĨ¤

â€ĸ Folate-responsive megaloblastic anemiaāĨ¤

â€ĸ Specific chemotherapy regimensāĨ¤

13. Drug Interactions and Contraindications

Interactions: Phenytoin, phenobarbital, primidone āĻāĻŦāĻ‚ fluoropyrimidines-āĻāϰ āϏāĻ™ā§āϗ⧇ clinically important interactions āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Contraindications: Hypersensitivity; untreated vitamin B12 deficiency-related pernicious anemia-āϤ⧇ folinic acid āĻāĻ•āĻž āϝāĻĨāĻžāϝāĻĨ treatment āύāϝāĻŧāĨ¤

14. Precautions and Warnings

Methotrexate āĻŦāĻž chemotherapy-associated āĻŦā§āϝāĻŦāĻšāĻžāϰ specialist-supervised āĻšāϤ⧇ āĻšāĻŦ⧇āĨ¤ Vitamin B12 deficiency āĻŦāĻžāĻĻ āĻĻ⧇āĻ“āϝāĻŧāĻž āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

15. Dosage and Administration

MedEx-āĻ folate-deficiency-associated megaloblastic anemia-āϰ āϜāĻ¨ā§āϝ 5–15 mg/day āωāĻ˛ā§āϞ⧇āĻ– āϰāϝāĻŧ⧇āϛ⧇āĨ¤ āĻ…āĻ¨ā§āϝ indications-āĻ dose āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āφāϞāĻžāĻĻāĻžāĨ¤

Prescription-āĻ āϏāĻŽā§āĻ­āĻŦāϤ 0+1+0āĨ¤

16. Pregnancy and Lactation

Pregnancy āĻāĻŦāĻ‚ lactation-āĻ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ benefit–risk assessment āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤

Clinical confidence: 0.99 for generic identity and pharmacology; 0.45 for patient-specific indication.


🩷 8. Bangladesh Clinical Practice — Cervical Erosion and Associated Disorders Medicines Used by Doctors

āĻāχ āĻ…āĻ‚āĻļāϟāĻŋ Bangladesh drug formulary āĻ“ guideline-based comparisonāĨ¤ āϏāĻŦāϗ⧁āϞ⧋ āĻ“āώ⧁āϧ cervical erosion-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύāϝāĻŧāĨ¤ āϝ⧇ āϰ⧋āĻ— āĻŦāĻž āϜāϟāĻŋāϞāϤāĻž āύāĻŋāĻļā§āϚāĻŋāϤ āĻšāĻŦ⧇, āĻļ⧁āϧ⧁ āϏ⧇āχ indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāĻž āĻšāĻŦ⧇āĨ¤

Table 1 — Bangladesh Clinical Drug Comparison

Generic Example Brand MedEx Therapeutic Class Relevant Condition Indicative Price
Flucloxacillin Fluclox 500 Narrow Spectrum Penicillin Susceptible Gram-positive infection ā§ŗ14/capsule
Ornidazole Ornil 500 Amoebicides, Anti-diarrhoeal Antiprotozoal Selected anaerobic/protozoal infection ā§ŗ7/tablet
Tiemonium Methylsulfate Algin 50 Anticholinergics Pelvic spasm ā§ŗ8.50/tablet
Paracetamol Napa 500 Non-opioid analgesic/antipyretic Postprocedural pain ā§ŗ1.20/tablet
Metronidazole Metryl 500 Amoebicides, Anti-diarrhoeal Antiprotozoal BV; part of PID regimens ā§ŗ2/tablet
Doxycycline Doxicap 100 Tetracycline antibiotic Selected cervicitis/PID regimens ā§ŗ2.20/capsule
Ceftriaxone Ceftron 500 mg IM Third-generation cephalosporin Gonorrhea/PID regimen component ā§ŗ200/vial
Clindamycin vaginal cream Clindacin 2% Lincosamide antibiotic BV alternative ā§ŗ70/20 g tube
Esomeprazole Esonix 20 Proton Pump Inhibitor Acid-related disorders ā§ŗ7/tablet
Levothyroxine Thyrox 50 mcg Thyroid Hormones Confirmed hypothyroidism ā§ŗ2.20/tablet
Folinic Acid Folix 5 Supportive Care Therapy Selected folate-related indications ā§ŗ9/tablet

Prices: MedEx-listed reference prices, not guaranteed current pharmacy selling prices.

Table 2 — Condition-Specific Evidence-Based Treatment Comparison

Confirmed Clinical Condition Guideline-Based Approach Why Used Important Restriction
Uncomplicated cervical ectropion Observation if asymptomatic Benign condition Routine antibiotics not indicated
Symptomatic persistent ectropion Specialist assessment; selected cautery/cryotherapy Treat troublesome symptoms Exclude infection and abnormal cervical pathology
Bacterial vaginosis Metronidazole or intravaginal clindamycin Treat vaginal anaerobic dysbiosis Diagnosis needed
Trichomoniasis Appropriate nitroimidazole regimen Eradicate T. vaginalis Partner treatment is important
Suspected PID Ceftriaxone + doxycycline + metronidazole, when outpatient regimen appropriate Broad coverage This is a combination regimen, not interchangeable individual options
Postprocedural infection Clinical assessment and infection-specific treatment Control infection Severe cases may require admission/IV antibiotics
Hypothyroidism Levothyroxine Hormone replacement TSH/FT4 monitoring
Confirmed folate-related anemia Appropriate folate therapy Correct deficiency Verify B12 status and exact indication

Confidence: 0.97 for guideline-based management principles.

Drug-Specific Bangladesh Clinical Practice Notes

1. Paracetamol — Napa 500 mg:

Generic: Paracetamol. āĻŦā§āϝāĻŦāĻšāĻžāϰ: postoperative pain/feverāĨ¤ MedEx price ā§ŗ1.20/unit; ā§ŗ12/stripāĨ¤ āϝāĻ•ā§ƒāϤ⧇āϰ āϰ⧋āĻ—, combination medicines āĻ“ total daily dose āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāϝāĻŧāĨ¤ MedEx—Napa

2. Metronidazole — Metryl 500 mg:

Generic: Metronidazole. āĻŦā§āϝāĻŦāĻšāĻžāϰ: symptomatic BV āĻ…āĻĨāĻŦāĻž broader PID regimen-āĻāϰ āĻ…āĻ‚āĻļāĨ¤ MedEx-listed price ā§ŗ2/unitāĨ¤ Pregnancy, interactions āĻāĻŦāĻ‚ treatment indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ regimen āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤ MedEx—Metronidazole Brands

3. Doxycycline — Doxicap 100 mg:

Generic: Doxycycline Hydrochloride. āĻŦā§āϝāĻŦāĻšāĻžāϰ: selected cervicitis āĻāĻŦāĻ‚ PID regimensāĨ¤ Price ā§ŗ2.20/capsule, ā§ŗ22/stripāĨ¤ Pregnancy-āϤ⧇ āϏāĻžāϧāĻžāϰāĻŖāϤ avoid āĻ•āϰāĻž āĻšāϝāĻŧ; indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āϞāĻžāϗ⧇āĨ¤ MedEx—Doxicap

4. Ceftriaxone — Ceftron 500 mg IM:

Generic: Ceftriaxone Sodium. āĻŦā§āϝāĻŦāĻšāĻžāϰ: gonococcal infection āĻāĻŦāĻ‚ guideline-based PID treatment-āĻāϰ injectable componentāĨ¤ Price ā§ŗ200/vialāĨ¤ Penicillin/cephalosporin allergy āĻāĻŦāĻ‚ weight/indication āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ regimen āϝāĻžāϚāĻžāχ āĻ•āϰāϤ⧇ āĻšāϝāĻŧāĨ¤ MedEx—Ceftriaxone Brands

5. Clindamycin vaginal cream — Clindacin 2%:

Generic: Clindamycin. āĻŦā§āϝāĻŦāĻšāĻžāϰ: symptomatic bacterial vaginosis-āĻāϰ local treatment optionāĨ¤ MedEx price ā§ŗ70/20 g tubeāĨ¤ Product-specific directions āĻ“ latex barrier contraception āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤ MedEx—Clindamycin Vaginal Cream


🟨 9. My Clinical Working Assessment

đŸŸĒ 9.1 Prescription-Ready Provisional Diagnosis

Postprocedural pelvic/lower abdominal pain with mild vaginal bleeding, approximately seven days following gynecological treatment documented for cervical erosion; rule out postprocedural infection or other complications. Associated history suggestive of treated subclinical hypothyroidism.

āĻŦāĻžāĻ‚āϞāĻž Diagnosis

āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āχāϰ⧋āĻļāύ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āϤāϞāĻĒ⧇āĻŸā§‡āϰ āĻŦā§āϝāĻĨāĻž āĻ“ āϏāĻžāĻŽāĻžāĻ¨ā§āϝ āϝ⧋āύāĻŋāĻĒāĻĨ⧇ āϰāĻ•ā§āϤāĻĒāĻžāϤ; āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϜāϟāĻŋāϞāϤāĻž āĻŦāĻžāĻĻ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤ āϏāĻ™ā§āϗ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϧ⧀āύ āϏāĻžāĻŦāĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻšāĻžāχāĻĒā§‹āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄāĻŋāϜāĻŽā§‡āϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āχāϤāĻŋāĻšāĻžāϏāĨ¤

Confidence: 0.84

đŸŸĒ 9.2 Specific Specialist Department / Doctor Referral

Primary referral: Consultant Obstetrician and Gynaecologist.

āĻŦāĻžāĻ‚āϞāĻž: āĻ¸ā§āĻ¤ā§āϰ⧀āϰ⧋āĻ— āĻ“ āĻĒā§āϰāϏ⧂āϤāĻŋāĻŦāĻŋāĻĻā§āϝāĻž āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžāĨ¤

Reason: Postprocedural pelvic pain, vaginal bleeding āĻāĻŦāĻ‚ cervical condition āĻĒ⧁āύāĻ°ā§āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύāĨ¤

Secondary referral: Endocrinologist, āϝāĻĻāĻŋ thyroid-function results abnormal āĻšāϝāĻŧ āĻ…āĻĨāĻŦāĻž thyroid treatment adjustment āϜāϟāĻŋāϞ āĻšāϝāĻŧāĨ¤

Confidence: 0.98

🟧 9.3 Clinical Diagnosis — Disease Severity / Category / Complications

Disease category: Postprocedural gynecological symptoms following treatment for documented cervical erosionāĨ¤

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āĻ¸ā§āĻ¤ā§āϰ⧀āϰ⧋āĻ—āϜāύāĻŋāϤ āωāĻĒāϏāĻ°ā§āĻ—āĨ¤

Severity: Undetermined — āĻ•āĻžāϰāĻŖ pain score, current bleeding volume, temperature āĻāĻŦāĻ‚ pelvic examination findings āύ⧇āχāĨ¤

Possible complications: Postprocedural endometritis, cervicitis, persistent cervical bleeding āĻ…āĻĨāĻŦāĻž āĻ…āĻ¨ā§āϝ uterine pathologyāĨ¤ āĻāϗ⧁āϞ⧋ differential diagnoses, confirmed complications āύāϝāĻŧāĨ¤

Confidence: 0.90 for the need to assess; insufficient data to assign complication probabilities.


10. Differential Diagnosis — āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āϰ⧋āĻ—āύāĻŋāĻ°ā§āĻŖāϝāĻŧ

Differential Diagnosis āĻŦāĻžāĻ‚āϞāĻž Evidence Supporting Consideration Confidence
Expected postoperative recovery āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āϏ⧇āϰ⧇ āĻ“āĻ āĻžāϰ āĻĒā§āϰāĻ•ā§āϰāĻŋāϝāĻŧāĻž Mild bleeding and pain after procedure 0.85
Postprocedural endometritis āϜāϰāĻžāϝāĻŧ⧁āϰ āϭ⧇āϤāϰ⧇āϰ āĻ¸ā§āϤāϰ⧇ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ Pain after uterine instrumentation 0.65
Cervicitis āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš Cervical history and bleeding 0.65
Persistent ectropion-related bleeding āχāĻ•āĻŸā§āϰ⧋āĻĒāĻŋāϝāĻŧāύāϜāύāĻŋāϤ āϰāĻ•ā§āϤāĻĒāĻžāϤ Documented cervical erosion history 0.75
Pregnancy-related bleeding āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻžāϜāύāĻŋāϤ āϰāĻ•ā§āϤāĻĒāĻžāϤ Reproductive-age patient; pregnancy status undocumented 0.50
Retained intrauterine tissue āϜāϰāĻžāϝāĻŧ⧁āϰ āϭ⧇āϤāϰ⧇ tissue āĻĨ⧇āϕ⧇ āϝāĻžāĻ“āϝāĻŧāĻž Relevant only if D&C and its indication are confirmed 0.45

These confidence scores reflect diagnostic plausibility, not calculated disease probabilities.


11. Investigations — āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āĻĒāϰ⧀āĻ•ā§āώāĻž

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϏāĻ™ā§āϗ⧇ āϕ⧋āύ⧋ laboratory āĻŦāĻž imaging report āϏāĻ‚āϝ⧁āĻ•ā§āϤ āύ⧇āχāĨ¤

Investigation Purpose āĻŦāĻžāĻ‚āϞāĻž
CBC Evaluate anemia or infection-associated changes āϰāĻ•ā§āϤāĻ¸ā§āĻŦāĻ˛ā§āĻĒāϤāĻž āĻ“ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ
Urine/serum β-hCG Exclude pregnancy-related causes when applicable āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻž-āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻ•āĻžāϰāĻŖ āĻŦāĻžāĻĻ āĻĻ⧇āĻ“āϝāĻŧāĻž
Speculum examination Assess cervix and bleeding source āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āĻ– āĻ“ āϰāĻ•ā§āϤāĻĒāĻžāϤ⧇āϰ āĻ‰ā§ŽāϏ āĻĻ⧇āĻ–āĻž
Bimanual pelvic examination Assess uterine/adnexal tenderness āϜāϰāĻžāϝāĻŧ⧁ āĻ“ āφāĻļāĻĒāĻžāĻļ⧇āϰ āĻ…āĻ‚āĻļ⧇ āĻŦā§āϝāĻĨāĻž āφāϛ⧇ āĻ•āĻŋ āύāĻž āĻĻ⧇āĻ–āĻž
Pelvic USG/TVS Evaluate uterine cavity if indicated āϜāϰāĻžāϝāĻŧ⧁āϰ āϭ⧇āϤāϰ⧇āϰ āĻ…āĻŦāĻ¸ā§āĻĨāĻž āĻĻ⧇āĻ–āĻž
Infection testing Identify suspected cervicitis/STI/vaginal infection āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻœā§€āĻŦāĻžāϪ⧁ āĻļāύāĻžāĻ•ā§āϤ
TSH, FT4 Confirm thyroid status āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄā§‡āϰ āĻ•āĻžāĻ°ā§āϝāĻ•āĻžāϰāĻŋāϤāĻž
Vitamin B12/folate tests If anemia or deficiency is suspected āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ⧇āϰ āϘāĻžāϟāϤāĻŋ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ
Cervical screening Age- and history-appropriate screening āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ precancerous āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āĻļāύāĻžāĻ•ā§āϤ

Confidence: 0.96 for the investigation framework.


12. Etiology and Pathophysiology — āϰ⧋āϗ⧇āϰ āĻ•āĻžāϰāĻŖ āĻ“ āĻĒā§āϰāĻ•ā§āϰāĻŋāϝāĻŧāĻž

Cervical ectropion

Estrogen-related epithelial changes-āĻāϰ āϏāĻ™ā§āϗ⧇ āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻāϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ benignāĨ¤

Confidence: 0.98

Postprocedural pain and bleeding

Cervical or uterine instrumentation-āĻāϰ āĻĒāϰ⧇ temporary tissue irritation, healing-related spotting āĻ…āĻĨāĻŦāĻž cramping āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Confidence: 0.95

Possible infection

Infection āĻšāϞ⧇ uterine/cervical inflammation, pelvic pain, fever āĻŦāĻž abnormal discharge āĻĻ⧇āĻ–āĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ āĻļ⧁āϧ⧁ antibiotic prescription āĻĨāĻžāĻ•āĻžāϰ āĻ•āĻžāϰāϪ⧇ infection confirmed āĻŦāϞāĻž āϝāĻžāϝāĻŧ āύāĻžāĨ¤

Confidence: 0.97

Subclinical hypothyroidism

TSH āĻŦ⧇āĻļāĻŋ āĻāĻŦāĻ‚ FT4 āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻĨāĻžāĻ•āϞ⧇ biochemical diagnosis āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤ āϰ⧋āĻ—ā§€āϰ āϕ⧋āύ⧋ thyroid report āύāĻž āĻĨāĻžāĻ•āĻžāϝāĻŧ diagnosis āϝāĻžāϚāĻžāχāϝ⧋āĻ—ā§āϝ āύāϝāĻŧāĨ¤

Confidence: 0.99 for definition; 0.70 for patient-specific possibility.


13. Management and Treatment — Guideline-Based Review

A. Cervical erosion/ectropion

Asymptomatic ectropion-āĻ observation āϝāĻĨ⧇āĻˇā§āϟ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ Persistent troublesome bleeding āĻŦāĻž discharge āĻĨāĻžāĻ•āϞ⧇ clinician assessment-āĻāϰ āĻĒāϰ⧇ selected local treatment āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

B. Postprocedural pain

āĻŦā§āϝāĻĨāĻž mild āĻ“ improving āĻšāϞ⧇ observation āĻāĻŦāĻ‚ appropriate analgesia āϝāĻĨ⧇āĻˇā§āϟ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ worsening pain, fever āĻ…āĻĨāĻŦāĻž heavy bleeding āĻĨāĻžāĻ•āϞ⧇ urgent assessment āϜāϰ⧁āϰāĻŋāĨ¤

C. Antibiotic appropriateness

Fluclox + Ornil combination āĻāϕ⧇ āϏāϰāĻžāϏāϰāĻŋ guideline-standard PID regimen āĻŦāϞāĻž āϝāĻžāϝāĻŧ āύāĻžāĨ¤

PID āϏāĻ¨ā§āĻĻ⧇āĻš āĻšāϞ⧇ CDC-recommended treatment-āĻ āϏāĻžāϧāĻžāϰāĻŖāϤ ceftriaxone, doxycycline āĻ“ metronidazole-āĻ­āĻŋāĻ¤ā§āϤāĻŋāĻ• regimen āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧāĨ¤ Confirmed postoperative infection-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āϧāϰāύ āĻ“ severity āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŋāϤ āĻšāϝāĻŧāĨ¤

D. Hypothyroidism

NICE NG145 āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ subclinical hypothyroidism-āĻ levothyroxine treatment decision TSH level, repeated measurements, symptoms āĻāĻŦāĻ‚ clinical circumstances-āĻāϰ āĻ“āĻĒāϰ āύāĻŋāĻ°ā§āĻ­āϰ āĻ•āϰ⧇āĨ¤

E. Folix

Folinic acid-āĻāϰ āϜāĻ¨ā§āϝ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ indication āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤ Cervical ectropion-āĻāϰ routine treatment āĻšāĻŋāϏ⧇āĻŦ⧇ āĻāϟāĻŋ āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻŋāϤ āύāϝāĻŧāĨ¤

Overall management review confidence: 0.96.


14. 🟩 Doctor's Diagnosis vs My Diagnosis — Areas of Agreement

â€ĸ Doctor: History of cervical erosionāĨ¤ My assessment: Documented cervical condition; ectropion āĻāĻ•āϟāĻŋ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ clinical interpretationāĨ¤ Agreement confidence: 0.94.

â€ĸ Doctor: Seven-day postoperative follow-upāĨ¤ My assessment: Postprocedural clinical stateāĨ¤ Agreement confidence: 0.95.

â€ĸ Doctor: Pelvic pain and mild vaginal bleedingāĨ¤ My assessment: Same presenting symptoms with complication assessmentāĨ¤ Agreement confidence: 0.96.

â€ĸ Doctor: Possible SCH and Thyrox treatmentāĨ¤ My assessment: Possible thyroid disorder requiring biochemical confirmationāĨ¤ Agreement confidence: 0.75.

Agreement Conclusion

Doctor's documented diagnosis and my clinical working assessment are broadly similar.

āϤāĻŦ⧇ āφāĻŽāĻžāϰ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύāϟāĻŋ symptom-based differential diagnosis āĻ“ medication audit-āĻāϰ āĻ•āĻžāϰāϪ⧇ āĻ•āĻŋāϛ⧁āϟāĻž āĻŦāĻŋāĻ¸ā§āϤ⧃āϤāĨ¤


15. 🟧 Doctor's Diagnosis vs My Diagnosis — Areas of Difference

Difference 1 — Procedure identification

Doctor's note: D&C and another cervical procedure may have been documented.

My assessment: Exact operative procedure cannot be confirmed from the handwriting alone.

Important: D&C is not a routine treatment for uncomplicated cervical ectropion. āϝāĻĻāĻŋ āϏāĻ¤ā§āϝāĻŋāχ D&C āĻšāϝāĻŧ⧇ āĻĨāĻžāϕ⧇, āϤāĻžāĻšāϞ⧇ āĻāϰ āφāϞāĻžāĻĻāĻž uterine indication āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ Operation note āϝāĻžāϚāĻžāχ āϜāϰ⧁āϰāĻŋāĨ¤

Confidence: 0.95

Difference 2 — Infection diagnosis

Doctor's prescription: Fluclox and Ornil.

My assessment: These medicines suggest that infection coverage may have been considered, but infection is not proven.

Confidence: 0.98

Difference 3 — Thyroid diagnosis

Doctor's note: Possible SCH.

My assessment: TSH āĻāĻŦāĻ‚ FT4 āĻ›āĻžāĻĄāĻŧāĻž SCH āĻŦāύāĻžāĻŽ overt hypothyroidism āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Confidence: 0.99

Difference 4 — Folix indication

Doctor prescribed: Folix 5 mg.

My assessment: Specific anemia, folate deficiency āĻ…āĻĨāĻŦāĻž folate-antagonist indication āύ⧇āχāĨ¤

Confidence: 0.99 for lack of documented indication.

Final Comparison Conclusion

The physician's documented clinical impression and the independent working diagnosis are substantially consistent, but the evidence is insufficient to confirm postoperative infection, exact procedure type or thyroid disease category.


16. Clinical Prescription Demo — Prescription-Ready Documentation

LIPU MED — Educational Clinical Note

Patient: Female, approximately 39 years

Visit: Gynecological postoperative follow-up

History: Cervical erosion; seven days after reported procedure

C/C: Pelvic pain and mild vaginal bleeding

Provisional Diagnosis

Postprocedural pelvic pain with mild vaginal bleeding following gynecological treatment for cervical erosion; rule out postoperative infection and other complications. Possible history of subclinical hypothyroidism.

āĻŦāĻžāĻ‚āϞāĻž Dx

āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āχāϰ⧋āĻļāύ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āϤāϞāĻĒ⧇āĻŸā§‡āϰ āĻŦā§āϝāĻĨāĻž āĻ“ āĻ…āĻ˛ā§āĻĒ āϰāĻ•ā§āϤāĻĒāĻžāϤ; āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϜāϟāĻŋāϞāϤāĻž āĻŦāĻžāĻĻ āĻĻāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϏāĻžāĻŦāĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻšāĻžāχāĻĒā§‹āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄāĻŋāϜāĻŽā§‡āϰ āĻĒā§‚āĻ°ā§āĻŦāχāϤāĻŋāĻšāĻžāϏāĨ¤

Rx — Original Prescription Record

Medicine Original Apparent Schedule Verification Required
Fluclox 500 mg 1+1+1 Confirm exact duration and indication
Ornil 500 mg 1+1+1 Confirm frequency and indication
Algin 50 mg 1+1+1 Confirm duration
Esonix 20 mg 1+0+1 Confirm indication and duration
Thyrox 50 mcg 1+0+0 Review TSH/FT4 and previous dose
Folix 5 mg 0+1+0 Confirm indication and duration

āĻāχ āĻŸā§‡āĻŦāĻŋāϞāϟāĻŋ original prescription transcription, āύāϤ⧁āύ prescription āύāϝāĻŧāĨ¤

Investigation Plan

Clinical examination-āĻāϰ āĻ­āĻŋāĻ¤ā§āϤāĻŋāϤ⧇ CBC, pregnancy test, pelvic examination, TVS, infection testing āĻ“ thyroid function testing āύāĻŋāĻ°ā§āĻŦāĻžāϚāύāĨ¤

Advice

Heavy vaginal bleeding, increasing pelvic pain, fever, fainting āĻŦāĻž foul-smelling discharge āĻšāϞ⧇ urgent gynecological assessmentāĨ¤

Specialist Referral

Consultant Obstetrician and Gynaecologist.

Thyroid abnormality āĻĨāĻžāĻ•āϞ⧇ Endocrinology reviewāĨ¤

Clinical documentation confidence: 0.96.


17. Overview / Summary, Actionable Plan and References

A. Overview / Summary

āĻāχ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ corrected clinical review āĻĨ⧇āϕ⧇ āĻŦā§‹āĻāĻž āϝāĻžāĻšā§āϛ⧇, āϰ⧋āĻ—ā§€ cervical erosion-āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āĻĒāϰ⧇ pelvic pain āĻ“ mild vaginal bleeding āύāĻŋāϝāĻŧ⧇ āĻĢāϞ⧋āφāĻĒ⧇ āĻāϏ⧇āϛ⧇āύāĨ¤

āĻ›āϝāĻŧāϟāĻŋ āĻ“āώ⧁āϧ⧇āϰ generic āĻāĻ–āύ MedEx āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āĻļāύāĻžāĻ•ā§āϤ āĻšāϝāĻŧ⧇āϛ⧇āĨ¤

Fluclox āĻāĻ•āϟāĻŋ penicillin antibioticāĨ¤

Ornil āĻāĻ•āϟāĻŋ nitroimidazole antimicrobialāĨ¤

Algin antispasmodicāĨ¤

Esonix gastric acid suppressantāĨ¤

Thyrox thyroid hormone replacementāĨ¤

Folix folinic acid preparationāĨ¤

āϤāĻŦ⧇ medication indication āĻāĻŦāĻ‚ āϰ⧋āϗ⧇āϰ definitive diagnosis-āĻāϰ āĻŽāĻ§ā§āϝ⧇ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ evidence gaps āϰāϝāĻŧ⧇āϛ⧇āĨ¤

Overall confidence: 0.84

B. Actionable Plan

Step 1: Original operation note āϏāĻ‚āĻ—ā§āϰāĻš āĻ•āϰ⧇ exact procedure āĻ“ indication āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 2: Original prescription-āĻāϰ Fluclox āĻ“ Ornil-āĻāϰ dosing schedule āĻāĻŦāĻ‚ duration āϝāĻžāϚāĻžāχ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 3: Postprocedural complication-āĻāϰ āϕ⧋āύ⧋ history āĻŦāĻž symptoms āĻĨāĻžāĻ•āϞ⧇ pelvic examination āĻāĻŦāĻ‚ clinically indicated investigations āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 4: Thyrox indication āϝāĻžāϚāĻžāχāϝāĻŧ⧇āϰ āϜāĻ¨ā§āϝ TSH/FT4 āĻāĻŦāĻ‚ previous thyroid records āĻĻ⧇āĻ–āϤ⧇ āĻšāĻŦ⧇āĨ¤

Step 5: Folix 5 mg āϕ⧇āύ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇āϛ⧇ āϤāĻž āϜāĻžāύāϤ⧇ CBC, B12/folate status āĻāĻŦāĻ‚ prior clinical history review āĻ•āϰāϤ⧇ āĻšāĻŦ⧇, āϝāĻĻāĻŋ clinically indicated āĻšāϝāĻŧāĨ¤

Step 6: Cervical screening history, HPV vaccination record āĻāĻŦāĻ‚ follow-up status āϝāĻžāϚāĻžāχ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤


C. References — Textbooks, Guidelines and Peer-Reviewed Journals

Standard Textbooks

1. Williams Gynecology, 4th edition. McGraw Hill. Relevant sections on benign cervical disorders, pelvic examination and gynecological proceduresāĨ¤

2. Dutta's Textbook of Gynecology. Relevant chapters on cervical pathology and operative gynecologyāĨ¤

3. Harrison's Principles of Internal Medicine. Relevant chapters on hypothyroidism and thyroid-function abnormalitiesāĨ¤

4. Katzung's Basic & Clinical Pharmacology. Relevant chapters on beta-lactam antibiotics, antiprotozoal agents, acid-suppressing drugs and thyroid hormonesāĨ¤

5. Goodman & Gilman's The Pharmacological Basis of Therapeutics. Relevant sections on antimicrobial pharmacology, folate metabolism and endocrine therapeuticsāĨ¤

Clinical Guidelines

1. NICE Guideline NG145 — Thyroid Disease: Assessment and Management. Original publication 2019; subsequently updated.

2. CDC Sexually Transmitted Infections Treatment Guidelines, 2021. Relevant sections on BV, cervicitis and PIDāĨ¤

3. ASCCP Risk-Based Management Guidelines, 2019, with updates through 2023. Relevant when cervical screening abnormalities are identifiedāĨ¤

Journal Articles with DOI

1. Jonklaas J, et al. Guidelines for the Treatment of Hypothyroidism. Thyroid. 2014;24(12):1670–1751.

DOI: 10.1089/thy.2014.0028āĨ¤

2. Perkins RB, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102–131.

DOI: 10.1097/LGT.0000000000000525āĨ¤

3. Perkins RB, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023. J Low Genit Tract Dis. 2024;28(1):3–6.

DOI: 10.1097/LGT.0000000000000788āĨ¤


Author: Md.Rafiqul Islam Lipu

Date: Friday, 16 October 2026

Time checked: 08:51 AM, Bangladesh Standard Time (UTC+06:00)

Publication: LIPU MED — Clinical Prescription Review

Final Working Diagnosis

English: Postprocedural pelvic pain with mild vaginal bleeding following gynecological treatment for documented cervical erosion; postoperative complications to be excluded. Possible history of treated subclinical hypothyroidism.

āĻŦāĻžāĻ‚āϞāĻž: āϜāϰāĻžāϝāĻŧ⧁āĻŽā§āϖ⧇āϰ āχāϰ⧋āĻļāύ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āϤāϞāĻĒ⧇āĻŸā§‡āϰ āĻŦā§āϝāĻĨāĻž āĻ“ āϏāĻžāĻŽāĻžāĻ¨ā§āϝ āϝ⧋āύāĻŋāĻĒāĻĨ⧇ āϰāĻ•ā§āϤāĻĒāĻžāϤāĨ¤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āϜāϟāĻŋāϞāϤāĻž āĻŦāĻžāĻĻ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤ āϏāĻ™ā§āϗ⧇ āĻĒā§‚āĻ°ā§āĻŦāĻŦāĻ°ā§āϤ⧀ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϧ⧀āύ āϏāĻžāĻŦāĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻšāĻžāχāĻĒā§‹āĻĨāĻžāχāϰāϝāĻŧ⧇āĻĄāĻŋāϜāĻŽā§‡āϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āχāϤāĻŋāĻšāĻžāϏāĨ¤

Final diagnostic confidence: 0.84/1.00.

Clinical verification status: āĻ›āϝāĻŧāϟāĻŋ āĻ“āώ⧁āϧ⧇āϰ āύāĻžāĻŽ āϏāĻ‚āĻļā§‹āϧāĻŋāϤ āĻ“ MedEx-āĻ āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤ āϤāĻŦ⧇ operation note, laboratory reports, examination findings āĻāĻŦāĻ‚ āĻ•āĻŋāϛ⧁ handwritten dose/duration āĻ…āĻ¸ā§āĻĒāĻˇā§āϟ āĻĨāĻžāĻ•āĻžāϝāĻŧ āĻāϟāĻŋāϕ⧇ definitive confirmed diagnosis āĻŦāĻž āύāϤ⧁āύ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top